Effect of Mazdutide on fatty pancreas
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether mazdutide, a medication that may help reduce fat in organs and aid weight loss, can reduce fat build-up in the pancreas for people who are overweight or obese. It might help improve metabolic health and reduce risks related to fatty pancreas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- Your body mass index (BMI) must be at least 28, or between 24 and 28 with at least one condition like high blood sugar, abnormal cholesterol, or high blood pressure.
- An MRI shows that you have a certain level of fat in your pancreas (at least 6%).
- You need to agree to keep a stable diet and exercise routine during the study.
- You must not have taken certain diabetes or weight-loss drugs recently, and you must not have a history of pancreatitis or other major medical conditions that would make the study unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining lifestyle changes (diet and exercise) with a medication called mazdutide can help adults with obesity lose weight and keep it off. Mazdutide is an injectable medication that may help reduce appetite and support weight management over 2 years.
This study looks at how fat is processed in the body for people with different health conditions, including obesity and type 2 diabetes. It aims to find new ways to improve treatment by understanding these differences.
This study tests if lowering insulin levels can reduce fat buildup in the liver for people with a fatty liver condition called MASLD. It's looking for adults who are overweight and have early signs of insulin resistance but not diabetes.
This study looks at liver fat and how to manage it in people with obesity. It may help find better ways to treat fatty liver disease.
This trial tests if tirzepatide, a diabetes and weight loss medication, can help improve fatty liver disease in people who are overweight or have obesity. It may offer a new treatment option for managing liver health.
This study tests whether mazdutide, a medicine that may help with weight and blood sugar, can reduce plaque buildup in the heart's arteries. It is for people who are overweight or obese and have some narrowing in their heart arteries but do not need immediate procedures like stents.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.